Plant ID: NPO1362
Plant Latin Name: Swertia paniculata
Taxonomy Genus: Swertia
Taxonomy Family: Gentianaceae
NCBI TaxonomyDB:
559637
Plant-of-the-World-Online:
n.a.
India
CA12; CA7; | |
NR3C1; | |
TYR; | |
HSD17B2; | |
AHR; HIF1A; | |
RAB9A; PAX8; LMNA; NPC1; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group C | NR3C1 | Glucocorticoid receptor | P04150 | CHEMBL2034 |
Oxidoreductase | TYR | Tyrosinase | P14679 | CHEMBL1973 |
Transcription Factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | PAX8 | Paired box protein Pax-8 | Q06710 | CHEMBL2362980 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 3.597E-09 | 6.602E-05 | CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 6.769E-08 | 2.106E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 5.982E-08 | 2.106E-04 | CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 7.457E-07 | 1.624E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 9.919E-07 | 1.661E-03 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0003824; catalytic activity | GO:0070576; vitamin D 24-hydroxylase activity | 2.186E-06 | 2.644E-03 | CYP1A1, CYP3A4 |
MF | GO:0005488; binding | GO:0051879; Hsp90 protein binding | 2.764E-06 | 3.168E-03 | AHR, HIF1A, NR3C1 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 4.370E-06 | 3.660E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0020037; heme binding | 4.095E-06 | 3.660E-03 | CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 4.370E-06 | 3.660E-03 | CYP1A2, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0101020; estrogen 16-alpha-hydroxylase activity | 7.279E-06 | 5.661E-03 | CYP1A1, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 9.921E-06 | 7.449E-03 | CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0002933; lipid hydroxylation | 1.091E-05 | 7.666E-03 | CYP1A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.091E-05 | 7.666E-03 | CYP1A2, CYP3A4 |
BP | GO:0032502; developmental process | GO:0048856; anatomical structure development | 1.254E-05 | 8.535E-03 | AHR, CYP1A1, CYP1A2, CYP1B1, HIF1A, HSD17B2, LMNA, PAX8, SMN1, SMN2, TYR |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 1.527E-05 | 9.236E-03 | CYP1A2, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.036E-09 | 3.626E-08 | CYP1A2, HSD17B2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.750E-07 | 6.562E-06 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.997E-07 | 6.997E-06 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 4.943E-06 | 4.325E-05 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 9.754E-06 | 6.828E-05 | HSD17B2, CYP1A1, CYP1B1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.157E-05 | 1.258E-04 | CYP1A2, CYP1A1, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.724E-04 | 1.192E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.543E-03 | 6.000E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 9.179E-05 | 4.590E-04 | CA12, CA7 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | NR3C1; TYR; |
J00-J99: Diseases of the respiratory system | Rhinitis | J00, J30, J31.0 | NR3C1; |
H60-H95: Diseases of the ear and mastoid process | Otitis externa | H60 | NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Xerophthalmia | E50.6-E50.7 | NR3C1; |
G00-G99: Diseases of the nervous system G00-G99 | Duchenne muscular dystrophy | G71.0 | NR3C1; |
H00-H59: Diseases of the eye and adnexa | Ocular disease | H00-H59 | NR3C1; |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatological disease | L00-L99 | NR3C1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatitis | L20-L30 | NR3C1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Cushing's disease | E24.0 | NR3C1; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
NA: NA | HIV infections | NA | AHR; |
G00-G99: Diseases of the nervous system G00-G99 | Multiple scierosis | G35 | NR3C1; |
C00-D49: Neoplasms | Multiple myeloma | C90 | AHR; |
NA: NA | Corticosteroid-responsive inflammation | NA | NR3C1; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | NR3C1; |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Melasma | L81.1 | TYR; |
C00-D49: Neoplasms | Melanoma | C43 | TYR; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | NR3C1; |
G00-G99: Diseases of the nervous system G00-G99 | Ataxia telangiectasia | G11.3 | NR3C1; |
J00-J99: Diseases of the respiratory system | Allergic rhinitis | J00, J30, J31.0, T78.4 | NR3C1; |
I00-I99: Diseases of the circulatory system | Pulmonary arterial hypertension | I27.0, I27.2 | HIF1A; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NR3C1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Spinal cord injury | S14, S24, S34 | NR3C1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A; |
NA: NA | Non-infectious rhinitis | NA | NR3C1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | NR3C1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Skin allergies | T78.4 | NR3C1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Severe mood disorders | F30-F39 | NR3C1; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; |
L00-L99: Diseases of the skin and subcutaneous tissue | Eczema | L20-L30 | NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Vitiligo | L80 | TYR; |